STUDY QUESTION: Is the spindle assembly checkpoint (SAC) active during human preimplantation development?
Introduction
It is well known that human preimplantation embryos frequently acquire chromosomal abnormalities. High frequencies of wholechromosome aneuploidies have been described in oocytes (Fragouli et al., 2006) as well as in embryos at different days of preimplantation development van Echten-Arends et al., 2011; Voet et al., 2011; Mertzanidou et al., 2013a, b) . Furthermore, embryos frequently display genetic mosaicism, and can consist of cells with two or more different chromosomal complements, either normal and abnormal, or different types of abnormal cells. It appears that preimplantation embryos can acquire aneuploidies at each stage of development, but that the first two to three mitotic divisions are more prone to aberrations (Mantikou et al., 2012; Mertzanidou et al., 2013a) . This is supported by the fact that embryos have higher levels of chromosomal abnormalities at the cleavage stages than during the blastocyst stages (Avo Santos et al., 2010; .
Currently, little is known on the origin of these abnormalities, and it is possible that the high frequency of mitotic errors in the human embryo is the result of a combination of several interrelated mechanisms. One of these mechanisms could be an atypical behaviour of the checkpoint controlling the proper distribution of chromosomes during cell division. During a normal somatic cell cycle, the segregation of sister chromatids during the M-phase is controlled by a complex control mechanism termed the spindle assembly checkpoint (SAC). The SAC delays the onset of the anaphase until all chromosomes are properly attached to the mitotic spindle during metaphase by inhibiting the anaphase-promoting complex induced degradation of Cyclin B (Musacchio and Salmon, 2007; Lara-Gonzalez et al., 2012; Musacchio and Ciliberto, 2012; London and Biggins, 2014) . Importantly, when the duration of the metaphase is too long, for example, when the cell is not capable of resolving a chromosome misalignment, apoptosis is normally triggered, favouring cell death over possible chromosomal abnormalities in the daughter cells (Harley et al., 2010; Terrano et al., 2010) . The inhibition of this Cyclin B degradation by the activated SAC is not absolute however. In cells that are able to survive a long mitotic arrest, such as embryonic stem cells (ESCs) (Mantel et al., 2007) , Cyclin B levels can fall below the critical threshold needed to maintain the mitotic arrest before the cells undergo apoptosis. This causes the cells to slip through the pro-metaphase arrest and continue mitosis without satisfying the SAC, which is termed uncoupling of the SAC from apoptosis (Brito and Rieder, 2006; Kurokawa and Kornbluth, 2010) . Incorrect SAC functionality is generally linked to aneuploidy, and is thought to be one of the driving mechanisms behind the genome instability seen in cancers (Wassmann and Benezra, 2001) . Therefore, it is not surprising that it has been hypothesized that the high frequency of chromosomal mis-segregation in human embryos may be caused by a SAC impairment at least during the cleavage stages (Wei et al., 2011; Vera-Rodriguez et al., 2015) .
The aim of this study was to carry out functional testing of the SAC in human embryos at different stages of preimplantation development and to evaluate whether prolonged metaphase arrest leads to apoptosis, as it does in somatic cells (Harley et al., 2010; Terrano et al., 2010) . For this, we exposed human embryos to the drug nocodazole, which induces depolymerization of microtubules. Because of this, sister chromatids are unable to stably attach to the mitotic spindle during prophase, which renders the cells incapable of satisfying the SAC. If the SAC is functional, applying nocodazole to actively dividing cells leads to a pro-metaphase arrest. After a certain period of time, depending on the cell type, the cell will start apoptosis as a protection mechanism against the creation of aneuploid daughter cells. However, in the case of uncoupling of the SAC from apoptosis initiation such as in ESCs, nocodazole-treated cells can continue their cell cycle after a transient arrest (Mantel et al., 2007) .
Materials and Methods

Source of embryos
The experiments were approved by the local Committee for Medical Ethics and the Federal Committee for Medical and Scientific Research on Human Embryos in vitro. Patients donating embryos for research signed an informed consent approved by the same committees. A total of 126 good-quality human embryos were analysed between Day 3 and Day 6 of preimplantation development. All embryos were derived from normally fertilized oocytes (2PN the day after oocyte retrieval and injection) with good morphology and developmental rate: G1 for the cleavage (Day 3) and compaction (Day 4) stages and blastulation (Day 5 and Day 6) with an A and B score for inner cell mass (ICM) and trophectoderm, according to Alpha Scientists (2011). Day-3 embryos were obtained after polar body biopsy and preimplantation genetic screening and were not judged transferable. Day-4 embryos were mainly obtained from patients seeking PGD for a monogenic disease at our IVF centre. The embryos underwent one-cell biopsy on Day 3 and affected embryos of good morphology were used for this study. Single-cell biopsied embryos are known to develop normally in vitro and have an implantation potential comparable to conventional IVF/ ICSI embryos (Goossens et al., 2008; De Vos et al., 2009) . Finally, embryos that were not transferred nor cryopreserved on Day 3, due to delayed development or PGD outcome, and were donated for research, were kept in culture and those that reached good morphology by Days 4, 5 or 6 were also used in this study. Relatively more embryos were assigned to the control group to compensate for the higher biological variation in untreated embryos compared to the nocodazole-treated group. All embryos were cultured individually in 25 microliter droplets of Q2 (Quinn's Advantage Plus Blastocyst Medium) medium (Sage In Vitro Fertilization, Origio, Denmark) under oil (Vitrolife, Sweden) (5% O 2 , 6% CO 2 and 89% N 2 ).
Time-lapse microscopy and nocodazole treatment
Embryos were incubated in Q2 medium that was pre-warmed to 37°C and equilibrated to 5% O 2 . After transferring the embryos to a new dish, they were placed in a humidified chamber at 5% O 2 and 37°C on the confocal microscope (IX71 Fluoview 300; Olympus, Belgium) for time-lapse imaging during 16 h using the 633 nm laser at minimal intensity (intervals of 6 min). For the nocodazole-treated group, 5 µM nocodazole (SigmaAldrich, Belgium) was added.
TUNEL assay and immunocytochemistry
Embryos were washed in phosphate-buffered saline (PBS; Sigma-Aldrich, Belgium) supplemented with 2% (w/v) bovine serum albumin (BSA; SigmaAldrich, Belgium) and fixed with 3.7% (v/v) formaldehyde (Merck; VWR International, Belgium) in PBS for 10 min at room temperature. After two washing steps of 5 min in PBS, embryos were permeabilised with 0.1% (v/v) Triton X-100 (Sigma-Aldrich, Belgium) and 0.1% (w/v) sodium citrate (Sigma-Aldrich,). After two more washing steps, the embryos were placed into the fluorescein-labelled Terminal deoxynucleotidyl transferase dUTP Nick End Labelling (TUNEL) reaction mixture (Roche, Belgium) and incubated at 37°C for 1 h. Subsequently, three more washes were performed, after which the primary antibody (anti-histone H3 phospho S10, Abcam, UK) or (anti-α-tubulin, Abcam, UK) was incubated overnight at 4°C in PBS with 2% (w/v) BSA. This was followed by three more washes with PBS, 1 h incubation with the secondary antibody (Alexa Fluor® 647-labelled antirabbit, Thermo Fisher Scientific, Belgium) at room temperature in PBS + 0.2% (w/v) BSA, three more PBS washes and finally mounting in SlowFade Gold Antifade with DAPI (Life Technologies, Belgium). Visualization was done with an IX71 Fluoview 300 confocal microscope (Olympus, Belgium). Image analysis was done using Volocity imaging software (Perkin Elmer, Belgium).
Fluorescence in situ hybridization (FISH)
Embryos were dissociated in 0.1% (v/v) Tween20 (Sigma-Aldrich, Belgium) in 0.01 N HCl by mouth-controlled pipetting on Superfrost Plus glass slides (Thermo Fisher Scientific, Belgium), isolating single blastomeres. After drying the slide for at least 15 min, slides were washed with PBS and dehydrated in a 70-90% to 100-100% (v/v) ethanol series. FISH was performed using the Vysis Multivision Pb Multi-color Probe set for chromosomes 13, 16, 18, 21 and 22 (Abbott Molecular, Belgium) following the manufacturers instructions and as previously described . For this, slides were re-hydrated with water and PBS, fixed for 10 min in 1:3 acetic acid and methanol, washed twice with PBS and twice with water and dehydrated again with a 70-90% to 100-100% (v/v) ethanol series. Probe mixture was applied, co-denaturation was performed at 73°C for 5 min and incubated overnight in a humidified chamber at 37°C. Post-hybridization washing was done in 0.4× SSC (Thermo Fisher Scientific, Belgium) for 2 min at 73°C, and 1 min in 2 × SSC/0.1% (v/v) NP-40 (Sigma-Aldrich, Belgium) at room temperature. After mounting with Vectashield with 4′,6-diamidino-2-phenylindole (Vector Labs, Brussels, Belgium), slides were analysed blindly, using a Zeiss axyoplan-2 microscope. Foci were considered as separate spots only if separated by at least 1× the size of a single focus.
Statistical analysis
The statistical significance of the differences in mitotic and apoptotic indexes were tested by a two-way ANOVA test using Graphpad Prism 6; differences were called significant when the P-values were 0.05 or lower.
Results
We used nocodazole to test the functionality of the SAC in human preimplantation embryos. This drug induces microtubule depolymerization, and hence blocks the formation of a proper spindle, which is crucial for the alignment of the chromosomes during metaphase. We chose to incubate the embryos overnight (16 h) with 5 µM nocodazole based on studies in mouse embryos (Kato and Tsunoda, 1992) , and in mouse and human ESCs (Mantel et al., 2007) . To control for the efficacy of the drug treatment, we analysed the tubulin-cytoskeleton of the cells by immunocytochemistry in 3-, 4-and 5-days old human embryos either treated with nocodazole or incubated in control medium (Fig. 1) . Here, we could show that in contrast to untreated embryos, the formation of the mitotic spindle in nocodazole-treated embryos is largely impaired, although not completely absent. The spindles of the nocodazole group are abnormal and strongly disorganized compared to normal prophase spindles (some clear examples are marked in Fig. 1 with a 'D' ), confirming the expected effect of the drug on the cells.
Next, a total number of 101 human preimplantation embryos at different developmental stages were incubated in nocodazole (n = 39) or control medium (n = 62) and observed using time-lapse microscopy. Figure 2 shows representative images of embryos at the start (late day 3, 4, 5 or 6) and the end (respectively, early day 4, 5, 6 or 7) of the incubation period. Videos of the time-lapses can be found in the Supplementary Materials. We found that, although the cells in all nocodazole-treated embryos stopped dividing, embryos incubated at Day 3 maintained their organization and in some cases the beginning of compaction could be observed. Starting incubation at Day 4, embryos showed signs of cavitation, as seen in the control group. This indicates that, although division stopped, the developmental clock of compaction and blastulation continued in the presence of the drug. Conversely, blastocysts incubated at Days 5 and 6 gradually collapsed and degenerated when exposed to nocodazole.
To clarify the effect of the drug on the cells, all embryos were fixed immediately after the incubation period and the mitotic index was determined by immunocytochemical staining for S10-phosphorylated histone H3 as a marker for cells in M-phase. Representative images can be found in Fig. 3A and B, the results are presented in Fig. 3C and Table I . In all groups, we found an increase in the percentage of cells in M-phase from 4.2-8.8% in the control group to 21.4-53.5% in the nocodazole-treated group. This increase was statistically significant (P < 0.05; two-way ANOVA) in all groups except for Day 4 embryos (P = 0.128; two-way ANOVA). Delayed progression through, or even arrest in, the M-phase when the formation of a proper metaphase plate is disturbed suggests that the SAC is active in embryos of all analysed developmental stages.
Counting the nuclei in the different groups shows that the nocodazole group incubated at Days 5 and 6 had a comparable number of nuclei as the non-treated group of a day earlier; for example, embryos exposed to nocodazole at Day 6 had 111 nuclei on average one day later, compared to 139 nuclei for the Day-5 control group one day later, i.e. Day 6 (Table I ). This indicates that the nocodazole treatment blocked cell division and exposed embryos did not increase their cell numbers. Conversely, the number of nuclei in the embryos exposed at Days 3 and 4 was similar in the nocodazole-treated group and the control group, despite the absence of cellular division detected using the time-lapse imaging. One possible explanation is that the cells start a new G1-phase without going through cell division, which is made impossible due to the microtubular disruption by the nocodazole treatment, and form one or more (micro-) nuclei around their nonarranged chromosomes. As can be appreciated in Fig. 3A , the nuclei are grouped two by two in the nocodazole-treated Day 3 embryos, suggesting that each cell contains more than one nucleus.
Cells with a significantly shorter cell cycle would accumulate faster in an induced cell cycle arrest, causing them to be arrested longer compared to slower cycling cells, experiencing a harsher stimulus. To control for a possible bias due to major fluctuations in cell cycle length between the different embryonic stages, we extrapolated cell-doubling times for the control embryos from the nuclei counts in Table I . We found varying theoretical doubling times of 20 h from Days 3 to 4 (1.2 doublings in 24 h), 13.3 h from Days 4 to 5 (1.8 doublings) and 21.8 doublings from Days 5 to 6 (1.1 doublings). These variations do not correlate with the mitotic indexes (Fig. 3C) however, indicating that such mentioned bias has no significant influence in our experimental setup.
Simultaneously to the S10-phosphorylated histone H3 staining, we quantified the number of apoptotic cells using the TUNEL assay. Apoptosis was rare in control embryos between Day 3 and Day 6 (Table I ). In embryos incubated in nocodazole at Day-3 and Day-4, the percentage of apoptotic cells remained very low and no differences were found between the nocodazole and the control group (Table I) , which indicates that the treatment did not induce apoptosis in those embryos. In contrast, we found an increase in apoptotic cells in the nocodazole-treated embryos from Day 5 onwards, which became statistically significant in Day-6 embryos (P < 0.01; two-way ANOVA). The increasing trend in the number of apoptotic cells in the nocodazole-treated embryos suggests that between Days 3 and 5 of human preimplantation development, the SAC functionality changes. At the earliest stages, the SAC appears not to be able to induce apoptosis and this changes from Days 4 to 5, causing the cells to die after a prolonged mitotic arrest.
In a last step, we tested whether the Days 3 and 4 embryos remain arrested in M-phase when exposed to nocodazole, or whether they escape the metaphase arrest, skip mitosis and enter a polyploid new G1-phase. For this, the chromosomal content of all blastomeres of Day 4 embryos was quantified using a multi-probe FISH for chromosomes 13, 16, 18, 21 and 22 after nocodazole treatment (N = 4) and in the control group (N = 4). The embryos were classified as tetraploid if at least four signals per chromosome were counted and diploid if fewer signals were detected. Due to the often chaotic and mosaic chromosomal status of human preimplantation embryos (Voet et al., 2011; Mertzanidou et al., 2013a; Spits et al., 2014) , we concluded this was the most secure approach to estimate the ploidy in the blastomeres. An example of these results can be found in Fig. 4A . We found that 12.5% ± 1.9% of the control blastomeres contained a 4N chromosomal content, and were thus in G2 or M-phase (Fig. 4B) . The phospho-H3 stainings showed 7.6% ± 1.6% of the embryonic cells to be in M-phase, leaving an extrapolated 4.9% of the blastomeres most likely to be in G2-phase at the time of analysis. For the nocodazole group, 26.5% ± 7.7% of the blastomeres was phospho-H3 positive, while FISH showed 47.8% ± 7.4% of the blastomeres being 4N, from which it can be estimated that 22.4% of the cells with a 4N content were not residing in M-phase. After subtraction of the 4.9% of cells in G2 from the control group, this leaves 17.5% of cells that probably started a polyploid new cell cycle after the failure to satisfy the SAC checkpoint. This calculation is an extrapolation, but since it is not feasible to isolate G1-phase blastomeres and subsequently define their ploidy, this is the most straightforward way possible to demonstrate that the embryos' cells are able to escape the M-phase arrest and start a new cell cycle.
Discussion
In this study, we performed functional experiments to investigate cause and effect of chromosomal mis-attachment in human preimplantation embryos. Our results indicate that the SAC can be activated at least from Day 3 of preimplantation development onwards, but that it is unable to induce apoptosis until Day 5. Also, before Day 5 of development, the embryos seem to be able to escape the nocodazoleinduced pro-metaphase block of the SAC by starting a polyploid new cell cycle. Taking all these data together, we propose that during the first 4 days of normal human embryonic development, blastomeres of early embryos with unresolved chromosome misalignments can continue cell division after a transient arrest in M-phase, resulting in aneuploid daughter cells. Our results and those of other groups fit well to explain the high incidence of chromosomally unbalanced cells in cleavage-stage embryos.
Our results suggest that human embryos have a functional SAC, capable of sensing microtubuli mis-attachment and of maintaining metaphase arrest. One footnote here is that we only tested the cells' reactivity to a complete disturbance of microtubule attachment, which might trigger a stronger reaction than a single mis-attached chromosome would. Also, we studied surplus embryos donated for research from clinical IVF and PGD cycles, and although only embryos of the correct developmental stage were used, and none with relevant genetic aberrations after PGD screening, this could have introduced a possible bias in the outcome of this study. Nevertheless, we show that embryos up to Day 5 are not undergoing apoptosis if after prolonged arrest the misalignments are not resolved. In our experimental setting, the cells were not capable of cytokinesis, and frequently appeared to start a new interphase. In a natural environment, without chemicals impairing cell division, our results suggest that embryonic cells are able to take one of two courses in case of improper metaphase plate formation: division without resolving the misalignment or starting a new interphase without division. The first scenario would result in asymmetric distribution of the chromosomes over the daughter cells, which is known to occur frequently (Vanneste et al., 2009; Mertzanidou et al., 2013a, b; Chow et al., 2014) . The latter would lead to multipolar spindle formation and cell division inducing the appearance of very complex karyotypes, often found in human embryos and termed cells with chaotic genetic content (Chatzimeletiou et al., 2005 (Chatzimeletiou et al., , 2012 Wong et al., 2010; Chavez et al., 2012; Mertzanidou et al., 2013a ; Figure 2 Time-lapse microscopy of control and nocodazole-treated human embryos. Still images of embryos at the different days of analysis, at the start (0 h) and the end (16 h) of the incubation period. The embryos in the nocodazole group were grown in medium containing 5 µM nocodazole. Scale-bar is 100 μm. -Rodriguez et al., 2015) . In all likelihood, the events leading to those two possible scenarios are different, but in both cases a differential response to the SAC is involved. As we know from previous studies using time-lapse in combination with genetic screening, the time between cleavages and their duration strongly correlate to aneuploidy (Chavez et al., 2012; Vera-Rodriguez et al., 2015) . An explanation for the delayed cell division observed in these studies could be a prometaphase arrest, in an attempt to solve chromosome misalignments. Given that during the cleavage stages this arrest does not result in apoptosis even if the cell does not resolve its chromosome misalignments, it is logical that cells with slower progression through division have a higher risk to yield aneuploid daughter cells. Finally, when reaching the blastocyst stage there is a drastic change in the embryo's cell cycle control, and the SAC becomes able to induce apoptosis, which is in line with recent data obtained in an in vitro mouse model (Bolton et al., 2016) .
Vera
The mechanism behind this uncoupling between apoptosis and SAC-mediated cell cycle arrest remains unclear. Our observations have led us to speculate on the question whether early human embryos really display checkpoint uncoupling, or whether they are simply unable to carry out apoptosis under any situation. Previous studies have shown that apoptosis is rare in human embryos until Day 5 (reviewed in Brison, 2000) , but it has been observed more frequently in the cells of the ICM of the blastocyst (Chi et al., 2011) . Also, Figure 3 Mitotic and apoptotic index of control and nocodazole-treated human embryos. Panels A and B show representative pictures of Day 3 (A) and Day 6 (B) embryos analysed after overnight culture in medium with or without 5 µM nocodazole. DNA is stained with DAPI, TUNEL (in green) marks apoptotic and necrotic cells, pH3 (in magenta) stands for 'phospho-histone H3' and labels M-phase DNA. Panel C shows the average percentage of cells per embryo in mitosis and apoptosis for each stage of development. N = 20, 6, 5 and 8 in the nocodazole group for Days 3, 4, 5 and 6, respectively. N = 12, 19, 18 and 13 in the control group for Days 3, 4, 5 and 6, respectively. Data are presented as means ± SEM, *P ≤ 0.05, **P ≤ 0.01, two-way ANOVA.
the mRNA-levels of the anti-apoptotic BCL2L10 are over 2600 times higher in zygotes than in blastocysts (Yan et al., 2013) , and the protein has been shown to decrease steadily from the zygote to the blastocyst stage (Guérin et al., 2013) . It is possible that these very high levels of BCL2L10 have such a strong anti-apoptotic effect, that it is almost impossible to induce apoptosis under physiologic conditions (Boumela et al., 2011) . Furthermore, analysing pro-apoptotic gene expression, the mRNA data shows that transcripts from genes such as BAX, BIX, NOXA and PUMA display very low levels in zygotes, but increase very quickly towards the morula stage (Yan et al., 2013) , supporting the notion that the pathways for apoptosis may be strongly suppressed until the cleavage stages. In contrast with all this, it has been shown that apoptosis can be induced in four-cell stage embryos by treating blastomeres with staurosporine, although higher concentrations are needed to trigger cell death than in blastocysts (Weil et al., 1996) . This shows that cleavage-stage embryos are indeed capable of activating programmed cell death under certain conditions. Although mostly descriptive data, they are in line with our findings.
In summary, our results suggest that the high incidence of aneuploid cells in human embryos may be mediated by the fact that, despite the presence of a functional SAC, pro-metaphase arrest caused by chromosomal misalignment does not result in apoptosis. Furthermore, the cells are able to escape the arrest and, under our experimental conditions, progress to a new interphase. This might suggest that during the cleavage stage, human preimplantation embryos seem to prefer a higher cell number over a correct genomic content, a problem left to deal with later in development. These data open the door to new research to understand how these genetically abnormal cells are cleared out in later stages of development, or if there are factors influencing the occurrence of abnormal spindle attachments during metaphase formation.
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